SCHEMBL6307363

SCHEMBL6307363

Cc1nc2ccc(C(=O)O)cc2n1Cc1ccc(-c2ccccc2)cc1Cl

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ PPARG P37231 5/20 0.51
▸ ALOX5AP P20292 4/20 0.47
▸ PTGES O14684 1/20 0.47
▸ ALOX5 P09917 1/20 0.47
▸ LTC4S Q16873 1/20 0.47
▸ HDAC1 Q13547 2/20 0.46
▸ HDAC6 Q9UBN7 2/20 0.46
▸ HDAC3 O15379 1/20 0.46
▸ HDAC4 P56524 1/20 0.46
▸ HDAC7 Q8WUI4 1/20 0.46
▸ HDAC2 Q92769 1/20 0.46
▸ HDAC10 Q969S8 1/20 0.46
▸ HDAC11 Q96DB2 1/20 0.46
▸ HDAC8 Q9BY41 1/20 0.46
▸ HDAC9 Q9UKV0 1/20 0.46
▸ HDAC5 Q9UQL6 1/20 0.46
▸ ACSS2 Q9NR19 1/20 0.44
▸ SPHK1 Q9NYA1 1/20 0.44
▸ ALDH1A1 P00352 1/20 0.43
▸ MAPT P10636 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6497415 0.94 PPARG (0.52) PPARGALOX5APPTGESALOX5LTC4S
SCHEMBL7651458 0.90 PPARG (0.56) PPARGALOX5APHDAC1HDAC6HDAC3
SCHEMBL6301641 0.89 PDE2A (0.51) PPARGHDAC1HDAC6HDAC3HDAC4
SCHEMBL6169166 0.88 PPARG (0.57) PPARGALOX5APPTGESALOX5LTC4S
SCHEMBL6170405 0.87 HDAC1 (0.59) PPARGALOX5APHDAC1HDAC6HDAC3
SCHEMBL6170044 0.87 PPARG (0.64) PPARGHDAC1HDAC6HDAC3HDAC4
SCHEMBL6491734 0.87 PPARG (0.53) PPARGALOX5AP
SCHEMBL6170384 0.87 HDAC1 (0.57) PPARGHDAC1HDAC6ACSS2SPHK1
SCHEMBL6307965 0.86 PPARG (0.47) PPARGALOX5APPTGESALOX5LTC4S
SCHEMBL6308006 0.86 PPARG (0.47) PPARGALOX5APPTGESALOX5LTC4S

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6869950-B1 Benzimidazole derivatives FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2005-03-22 — — US disclosed
US-6420409-B1 GLUCOSE TOLERANCE, DIABETES,INSULIN RESISTANCE, POLYCYSTIC OVARY SYNDROME, HYPERLIPIDEMIA, ATHEROSCLEROSIS, CARDIOVASCULAR DISORDERS, HYPERGLYCEMIA, HYPERTENSION, STENOCARDIA, PULMONARY HYPERTENSION, CONGESTIVE HEART FAILURE, FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2002-07-16 — — US disclosed
EP-1142880-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-10-10 — — EP disclosed
EP-1020452-A1 BENZIMIDAZOLE DERIVATIVES FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2000-07-19 — — EP disclosed
Send feedback